We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
Halo nevi and the Vogt-Koyanagi-Harada syndrome. Manifestations of vitiligo.
Archives of Dermatology 1980 June
A 10-year-old boy with Vogt-Koyanagi-Harada syndrome had loss of pigment cells in the skin, the halo nevi, the retina, and probably the leptomeninges. The amount of inflammation that accompanied destruction of pigment cells varied greatly and seemed to determine whether the patient had symptoms from his vitiligo. This patient exhibited symptoms associated with loss of pigment cells in his skin and leptomeninges, but not from the destruction of the pigment cells in his eyes. We suggest that vitiligo is a disease that can be manifested in any tissue containing pigment cells and has a variable clinical expression.
Full text links
Trending Papers
Acute and non-acute decompensation of liver cirrhosis (47/130).Liver International : Official Journal of the International Association for the Study of the Liver 2024 March 2
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM).Clinical Infectious Diseases 2024 March 6
Ten Influential Point-of-Care Ultrasound Papers: 2023 in Review.Journal of Intensive Care Medicine 2024 Februrary 20
Administration of methylene blue in septic shock: pros and cons.Critical Care : the Official Journal of the Critical Care Forum 2024 Februrary 17
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app